Wellbutrin Drug Cos. Were Anti-Competitive: Suit
A drug distribution company has filed a proposed antitrust class action against Biovail Corp. and GlaxoSmithKline Corp. alleging that the two companies filed frivolous patent lawsuits to keep a generic version...To view the full article, register now.
Already a subscriber? Click here to view full article